Macrophage inflammatory protein (MIP)-1α, a CC chemokine, enhances proliferation of mature subsets of myeloid progenitor cells (MPCs), suppresses proliferation of immature MPCs, and mobilizes mature and immature MPCs to the blood. MIP-1α binds at least three chemokine receptors. To determine if CCR1 was dominantly mediating the above activities of MIP-1α, CCR1-deficient (−/−) mice, produced by targeted gene disruption, were used. MIP-1α enhanced colony formation of marrow granulocyte/macrophage colony-forming units (CFU-GM), responsive to stimulation by granulocyte/macrophage colony-stimulating factor (GM-CSF), and CFU-M, responsive to stimulation by M-CSF, from littermate control CCR1+/+ but not CCR1−/− mice. Moreover, MIP-1α did not mobilize MPCs to the blood or synergize with G-CSF in this effect in CCR1−/− mice. However, CCR1−/− mice were increased in sensitivity to MPC mobilizing effects of G-CSF. Multi-growth factor–stimulated MPCs in CCR1−/− and CCR1+/+ marrow were equally sensitive to inhibition by MIP-1α. These results implicate CCR1 as a dominant receptor for MIP-1α enhancement of proliferation of lineage-committed MPCs and for mobilization of MPCs to the blood. CCR1 is not a dominant receptor for MIP-1α suppression of MPC proliferation, but it does negatively impact G-CSF–induced MPC mobilization.
Skip Nav Destination
Article navigation
21 June 1999
Brief Definitive Report|
June 21 1999
Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1
Hal E. Broxmeyer,
Hal E. Broxmeyer
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Scott Cooper,
Scott Cooper
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Giao Hangoc,
Giao Hangoc
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Ji-Liang Gao,
Ji-Liang Gao
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Philip M. Murphy
Philip M. Murphy
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Hal E. Broxmeyer
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Scott Cooper
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Giao Hangoc
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Ji-Liang Gao
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Philip M. Murphy
From the *Department of Microbiology/Immunology, the Department of Medicine, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202; the ‡Walther Cancer Institute, Indianapolis, Indiana 46208; and the §Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Address correspondence to Hal E. Broxmeyer, Walther Oncology Center, Indiana University School of Medicine, 1044 West Walnut St., Indianapolis, IN 46202-5254. Phone: 317-274-7510; Fax: 317-274-7592; E-mail: [email protected]
Received:
February 22 1999
Revision Received:
April 23 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (12): 1987–1992.
Article history
Received:
February 22 1999
Revision Received:
April 23 1999
Citation
Hal E. Broxmeyer, Scott Cooper, Giao Hangoc, Ji-Liang Gao, Philip M. Murphy; Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1 . J Exp Med 21 June 1999; 189 (12): 1987–1992. doi: https://doi.org/10.1084/jem.189.12.1987
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement